Monthly Archives November 2019

As advised via PHARMAC Tender Results of 29 November 2019 there is to be a change in the listing and future sole supply of Olopatadine eye drops. New listing from 1 May 2020 Olopatadine Eye Drops 0.1% 5 ml OP                                                                                 Pharmacode TBA                  Schedule price $2.20 Incumbent brand Patanol Eye drops 0.1% 5 ml OP                                                                                          Pharmacode 2099365        …

  As advised via PHARMAC proposal of 28 November 2019 there is to be a change in the listing and future sole supply of labetalol. New listing from 1 April 2020 Trandate Tab 100 mg 100                                                                                                      Pharmacode TBA                  Schedule price $00.00 Trandate Tab 200 mg 100                                                                                                      Pharmacode TBA                  Schedule price $00.00 Incumbent brands Presolol Tab…

Click here to access the analysis for Fluticasone Click here to access the analysis for Fluticasone with salmeterol Click here to access the analysis for Meterol. As per our Mind Time notification of 23 October 2019, PHARMAC have proposed to award sole supply for Fluticasone to Flixotide and Fluticasone with salmeterol to Seretide effective from 1 September 2020. This provides…

Click here to access the analysis Suboxone Tab. In association with Indivior we are pleased to be able to offer this additional discount, which will make it more profitable for your pharmacy to stay with Suboxone and delay the required brand change (which your patient will appreciate) until closer to the end of the dual listing period around March 2020.…

Mylan have advised that the original registered product (as shown above) is now available for supply. ProPharma / PWR will not release this stock until such time all of the alternative Section 29 product has sold through. In fact it is in your best interest from a funding perspective to continue to use Section 29 product. Alternative product (shown below)…

We have received the following notification of a change which will directly affect all those who order Biomed Section 26 and Section 29 items not currently stocked by ProPharma /PWR on an as required basis. (Please note this change does not affect the current Website ordering process and charges) Freight charges for orders Biomed provide 1 free delivery per week…

Click here to read the original notifications for Chlorapmphenicol Eye Ointment 1% 5 gm, Clopidogrel Tablets 75 mg, Droperidol Injection 2.5 mg, Temozolomide Cap 5 mg, Temozolomide Cap revised and Tranexamic Acid Tab 500 mg. Most of these products will have DUAL listings in the Pharmaceutical Schedule & where applicable HML from 1 December 2019 until 30 April 2020. We…

Previous notification 15 April 2019. Click here to read the supplier update notification of a temporary shortage of the above mentioned product. ProPharma / PWR have no stock of either line. Heparin Inj 25000IU/ml 0.2 ml Ampoule 5 Pharmacode 333085 ProPharma / PWR have no stock. As stated alternatives are available on request. Together we can make this a seamless…

Click here to read the notification of 18 November 2019 from Mylan. Please take special note of the information contained and note the following additional information. Fluox Cap 20 mg 84 and Fluox Tab dispersible 20 mg 30 were listed in the Pharmaceutical Schedule from 1 November 2019 and are to be delisted from 1 December 2019. Both Fluox Cap…

Close